RESUMO
Venous thromboembolic disease is the leading preventable cause of hospital mortality. Up to 75 percent of these are in non - surgical patients. This is a large, heterogeneous group of patients; so to know the risk factors for deep venous thrombosis crucial to provide a correct prevention. This article reviewed the indications, contraindications and complications of thromboprophylaxis. Difficult cases in elderly, obese, chronic kidney disease, critical care and cirrhotic patients were reviewed. The purpose of this article is to support decision making on dvt prevention in hospitalized medical patients...
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Anticoagulantes/uso terapêutico , Hospitalização , Tromboembolia Venosa/complicações , Tromboembolia Venosa/prevenção & controle , Fatores de RiscoRESUMO
The aim of this study is to evaluate the use of thromboprophylaxis in surgical oncology patients in HCUCH in 2011. Method: Retrospective analysis of patients with cancer undergoing surgery in 2011. Was defined as adequate pharmacological thromboprophylaxis the correct dose, mechanical prophylaxis in case of drug contraindications and beginning on day 0 or 1. Results: 131 medical records were reviewed. Main neoplasms were colorectal (21.3 percent), prostate (12.9 percent), gallbladder (8.3 percent) and stomach (6.9 percent). Of the patients requiring pharmacologic thromboprophylaxis (n = 110) were rated as adequate 52 patients (47 percent), 47 inadequate (43 percent) and 11 absent (10 percent). The causes of inappropriate use of pharmacological thromboprophylaxis included 27 late onset (58 percent), 10 lower doses (21 percent), 3 late onset associated with lower dose (6 percent), 6 incomplete thromboprophylaxis (13 percent) and 1 dose increased (2 percent). Factors significantly associated with pharmacological thromboprophylaxis absent were: <40 years of age (p = 0.002), head and neck cancer (p < 0.001), and hospital stay <7 days (p < 0.001). Conclusions: The absence of pharmacological thromboprophylaxis is associated with lower absolute risk factors for VTE: Age less than 40 years old, head and neck cancer, hospital stay less than 7 days...
Assuntos
Humanos , Masculino , Adulto , Feminino , Pessoa de Meia-Idade , Idoso de 80 Anos ou mais , Anticoagulantes/administração & dosagem , Anticoagulantes/efeitos adversos , Tromboembolia Venosa/epidemiologia , Tromboembolia Venosa/etiologia , Tromboembolia Venosa/prevenção & controle , ChileRESUMO
Internal Medicine is a basic clinical specialty in Medicine, but due to its vast field of action it is quite difficult to define. This consensus article analyzes different definitions and proposes a current definition while analyzing several aspects of the specialty along with its strengths and weaknesses. We propose to define Internal Medicine as a clinical specialty devoted to the comprehensive care of adults, from adolescence to senility, particularly the diagnosis and non surgical treatment as well as primary and secondary prevention of their diseases, in hospital or ambulatory settings. We propose to define Internal Medicine as a clinical specialty devoted to the comprehensive care of adults in hospital or ambulatory settings, from adolescence to end of life, in terms of prevention, diagnosis and non-surgical treatments of disease.
Assuntos
Humanos , Medicina Interna , Internato e Residência , Chile , Sociedades MédicasRESUMO
La Miastenia Grave (MG) es una enfermedad autoinmune que caracteriza por presentar debilidad generalizada de la musculatura esquelética y que es relativamente frecuente en la población general. Por otra parte, el embarazo es una condición de strees físico e inmunosupresión, con el siguiente riesgo de gatillar o exacerbar crisis miaténicas, que pueden complicar el trabajo de parto o causar paro respiratorio. Se presenta el caso clínico de una paciente embarazada y portadora de una Miatenia grave atendida en el Servicio de Ginecología y Obstetricia del Hospital San Juan de Dios entre febrero y marzo de 2005. Se analizan aspectos relevantes de la relación entre ambas entidades clínicas y su manejo.
Assuntos
Humanos , Feminino , Adulto , Miastenia Gravis/diagnóstico , Miastenia Gravis/terapia , Complicações na Gravidez , Estudos de Casos e Controles , GravidezRESUMO
Objetivo: Evaluar la frecuencia de tumores anexiales en el embarazo, la histología tumoral y los resultados perinatales. Pacientes y método: Análisis retrospectivo de 33 pacientes con diagnóstico de tumor anexial y embarazo atendidas en el Servicio de Obstetricia del Hospital San Juan de Dios entre febrero de 2001 a julio de 2004. Resultados: La asociación tumor anexial y embarazo fue 1 en 424 embarazos. El tipo histológico más frecuente fue el cistoadenoma seroso (19,2 por ciento no alteró el pronóstico perinatal. Conclusión: Recomendamos la resolución quirúrgica de las masas anexiales complejas durante el embarazo sobre las 12 semanas, período que da un margen de seguridad bastante amplio sin afectar la evolución del embarazo o los resultados perinatales.